420
Views
21
CrossRef citations to date
0
Altmetric
Research Article

Preparation and characterization of letrozole-loaded poly(d,l-lactide) nanoparticles for drug delivery in breast cancer therapy

, &
Pages 235-242 | Received 07 Feb 2018, Accepted 19 Mar 2018, Published online: 05 Apr 2018

References

  • Astete CE, Kumar CSSR, Sabliov CM. 2007. Size control of poly(d,l-lactide-co-glycolide) and poly(d,l-lactide-co-glycolide)-magnetite nanoparticles synthesized by emulsion evaporation technique. Colloids Surf A. 299:209–216.
  • Azizi S, Norouzian D. 2015. Characteristics of pegylated niosomal letrozole. J Chem Pharm Res. 7:423–427.
  • Balzus B, Colombo M, Sahle FF, Zoubari G, Staufenbiel S, Bodmeier R. 2016. Comparison of different in vitro release methods used to investigate nanocarriers intended for dermal application. Int J Pharm. 513:247–254.
  • Belbella A, Vauthier C, Fessi H, Devissaguet JP, Puisieux F. 1996. In vitro degradation of nanospheres from poly(D,L-lactides) of different molecular weights and polydispersities. Int J Pharm. 129:95–102.
  • Coates AS, Keshaviah A, Thürlimann B, Mouridsen H, Mauriac L, Forbes JF, Paridaens R, Castiglione-Gertsch M, Gelber RD, Colleoni M, et al. 2007. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1–98. J Clin Oncol. 25:486–492.
  • Cohen-Sela E, Chorny M, Koroukhov N, Danenberg HD, Golomb G. 2009. A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles. J Control Release. 133:90–95.
  • Damitz R, Chauhan A. 2015. Rapid dissolution of propofol emulsions under sink conditions. Int J Pharm. 481:47–55.
  • DeSantis CE, Fedewa SA, Goding Sauer A, Kramer JL, Smith RA, Jemal A. 2015. Breast cancer statistics, 2015: convergence of incidence rates between black and white women. CA Cancer J Clin. 66:31–42.
  • Egorova EM, Dukhin AS, Svetlova IE. 1992. Some problems of zeta potential determination in electrophoretic measurements on lipid membranes. Biochim Biophys Acta. 1104:102–110.
  • Fallowfield L, Atkins L, Catt S, Cox A, Coxon C, Langridge C, Morris R, Price M. 2006. Patients’ preference for administration of endocrine treatments by injection or tablets: results from a study of women with breast cancer. Ann Oncol. 17:205–210.
  • Hortobagyi GN, de la Garza Salazar J, Pritchard K, Amadori D, Haidinger R, Hudis CA, Khaled H, Liu MC, Martin M, Namer M, et al. 2005. The global breast cancer burden: variations in epidemiology and survival. Clin Breast Cancer. 6:391–401.
  • Iqbal M, Zafar N, Fessi H, Elaissari A. 2015. Double emulsion solvent evaporation techniques used for drug encapsulation. Int J Pharm. 496:173–190.
  • Jensen DMK, Cun D, Maltesen MJ, Frokjaer S, Nielsen HM, Foged C. 2010. Spray drying of siRNA-containing PLGA nanoparticles intended for inhalation. J Control Release. 142:138–145.
  • Kadam AN, Najlah M, Wan KW, Ahmed W, Crean SJ, Phoenix DA, Taylor KM, Elhissi AM. 2014. Stability of parenteral nanoemulsions loaded with paclitaxel: the influence of lipid phase composition, drug concentration and storage temperature. Pharm Dev Technol. 19:999–1004.
  • Kato Y, Ozawa S, Miyamoto C, Maehata Y, Suzuki A, Maeda T, Baba Y. 2013. Acidic extracellular microenvironment and cancer. Cancer Cell Int. 13:89.
  • Kumar Jana S. 2014. Letrozole and curcumin loaded-PLGA nanoparticles: a therapeutic strategy for endometriosis. J Nanomedine Biotherapeutic Discov. 4:1–10.
  • La Saponara V. 2011. Environmental and chemical degradation of carbon/epoxy and structural adhesive for aerospace applications: fickian and anomalous diffusion, Arrhenius kinetics. Compos Struct. 93:2180–2195.
  • Mandal B, Dey SK, Bhowmik M, Ghosh LK. 2009. Development and in vitro evaluation of Letrozole loaded biodegradable nanoparticles for breast cancer therapy. Braz J Pharm Sci. 45:585–591.
  • Masood F. 2016. Polymeric nanoparticles for targeted drug delivery system for cancer therapy. Mater Sci Eng C. 60:569–578.
  • Mondal N, Pal TK, Ghosal SK. 2008. Development, physical characterization, micromeritics and in vitro release kinetics of letrozole loaded biodegradable nanoparticles. Pharmazie. 63:361–365.
  • Mukerjee A, Vishwanatha JK. 2009. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy. Anticancer Res. 29:3867–3875.
  • Nerella A, Basava R, Devi A. 2014. Formulation, optimisation and in vitro characterisation of letrozole loaded solid lipid nanoparticles. Int J Pharm Sci Drug Res. 6:183–188.
  • Öcal H, Arıca-Yegin B, Vural I, Goracinova K, Çalış S. 2014. 5-Fluorouracil-loaded PLA/PLGA PEG-PPG-PEG polymeric nanoparticles: formulation, in vitro characterization and cell culture studies. Drug Dev Ind Pharm. 40:560–567.
  • Oh IJ, Oh JY, Lee KC. 1993. Assessment of biodegradability of polymeric microspheresin vivo: poly (DL-lactic acid), poly (L-lactic acid) and poly (DL-lactide-co-glycolide) microspheres. Arch Pharm Res. 16:312–317.
  • Palamoor M, Jablonski MM. 2014. Comparative study on diffusion and evaporation emulsion methods used to load hydrophilic drugs in poly(ortho ester) nanoparticle emulsions. Powder Technol. 253:53–62.
  • Park MH, Jun HS, Jeon JW, Park JK, Lee BJ, Suh GH, Park JS, Cho CW. 2016. Preparation and characterization of bee venom-loaded PLGA particles for sustained release. Pharm Dev Technol. [accessed 2016 Dec 14]:[8 p.]. DOI:10.1080/10837450.2016.1264415
  • Park TG. 1994. Degradation of poly(d,l-lactic acid) microspheres: effect of molecular weight. J Control Release. 30:161–173.
  • Pearce L. 2016. Breast cancer. Nurs Stand. 30:15.
  • Peppas NA. 2011. Higuchi equation: derivation, applications, use and misuse. Int J Pharm. 418:6–12.
  • Petropoulos JH, Papadokostaki KG, Sanopoulou M. 2012. Higuchi’s equation and beyond: overview of the formulation and application of a generalized model of drug release from polymeric matrices. Int J Pharm. 437:178–191.
  • Rask MB, Knopp MM, Olesen NE, Holm R, Rades T. 2016. Influence of PVP/VA copolymer composition on drug-polymer solubility. Eur J Pharm Sci. 85:10–17.
  • Rosca ID, Watari F, Uo M, Uo M. 2004. Microparticle formation and its mechanism in single and double emulsion solvent evaporation. J Control Release. 99:271–280.
  • Saboktakin MR, Tabatabaie RM, Maharramov A, Ramazanov MA. 2011. Synthesis and in vitro studies of biodegradable thiolated chitosan hydrogels for breast cancer therapy. Int J Biol Macromol. 48:747–752.
  • Scott LJ, Keam SJ. 2006. Letrozole: in postmenopausal hormone-responsive early-stage breast cancer. Drugs. 66:353–362.
  • Siepmann J, Siepmann F. 2008. Mathematical modeling of drug delivery. Int J Pharm. 364:328–343.
  • Simpson D, Curran MP, Perry CM. 2004. Letrozole: a review of its use in postmenopausal women with breast cancer. Drugs. 64:1213–1230.
  • Sun L, Wu Q, Peng F, Liu L, Gong C. 2015. Strategies of polymeric nanoparticles for enhanced internalization in cancer therapy. Colloids Surf B Biointerfaces. 135:56–72.
  • Thürlimann B, Keshaviah A, Coates AS, Mouridsen H, Mauriac L, Forbes JF, Paridaens R, Castiglione-Gertsch M, Gelber RD, Rabaglio M, et al. 2005. A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. N Engl J Med. 353:2747–2757.
  • Tuba F, Oláh L, Nagy P. 2011. Characterization of reactively compatibilized poly(d,l-lactide)/poly(ε-caprolactone) biodegradable blends by essential work of fracture method. Eng Fract Mech. 78:3123–3133.
  • Tsuji H, Tsuruno T. 2010. Accelerated hydrolytic degradation of poly(l-lactide)/poly(d-lactide) stereocomplex up to late stage. Polym Degrad Stabil. 95:477–484.
  • Vauthier C, Dubernet C, Chauvierre C, Brigger I, Couvreur P. 2003. Drug delivery to resistant tumors: the potential of poly(alkyl cyanoacrylate) nanoparticles. J Control Release. 93:151–160.
  • Venkateswarlu V, Manjunath K. 2004. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. J Control Release. 95:627–638.
  • Youlden DR, Cramb SM, Dunn NAM, Muller JM, Pyke CM, Baade PD. 2012. The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol. 36:237–248.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.